Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gonadotropin-releasing hormone receptor (GnRHR) is a G protein-coupled receptor (GPCR) that mediates the action of gonadotropin-releasing hormone (GnRH), a key regulator of reproductive function. It is primarily expressed on pituitary gonadotrope cells, controlling the synthesis and secretion of LH and FSH. Upon binding GnRH, the receptor activates Gq/11 proteins, triggering phospholipase C activation, leading to increased inositol phosphate production, calcium mobilization, and protein kinase C activation, ultimately resulting in LH and FSH release. Mutations can cause congenital hypogonadotropic hypogonadism, and pharmacological modulation is used for infertility treatment and management of sex steroid-dependent diseases such as uterine fibroids, endometriosis, and prostate cancer.
GnRH agonists stimulate the receptor leading to initial gonadotropin release, but prolonged use causes desensitization/downregulation. GnRH antagonists block the receptor activity, reducing sex steroid production.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gonadotropin-Releasing Hormone Receptor (GnRHR).